Figure 3 | Scientific Reports

Figure 3

From: Anti-SARS-CoV-2 antibody levels predict outcome in COVID-19 patients with type 2 diabetes: a prospective cohort study

Figure 3

Odds ratios and adjusted odds ratios for each outcome in the whole cohort, in patients with type 2 diabetes, in non-diabetic patients and in matched, non-diabetic patients by anti-SARS-CoV-2 spike antibodies after z-score normalization. Hazard ratios and adjusted hazard ratios are given for mortality. Adjusted odds ratios are adjusted for age, obesity and SARS-CoV-2-variant.

Back to article page